VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
MinerviniVCP SetupsTrend Template
O'NeilCup with HandleFlat BaseDouble BottomCANSLIM Leaders
QullamaggieHigh Tight FlagsFlag BreakoutsEpisodic PivotsMomentum Leaders
KellWedge PopEMA Crossback
LivermorePivotal Points
PatternsFalling Wedge & ChannelBase Breakouts
View All Playbooks...
BreakoutsScanner
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
BreakoutsScanner
WatchlistPricing
Ctrl K
Pricing
FLNA
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Scanner
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsScannerWatchlist
FLNAFilana Therapeutics, Inc.
$0.45$22M
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
HomeStocksFLNAQuarterly Balance Sheet

Filana Therapeutics, Inc. (FLNA) Quarterly Balance Sheet

120+ quarters historyFree accessUpdated daily

Filana Therapeutics, Inc. (FLNA) quarterly balance sheet — complete assets, liabilities & equity history

Income StatementBalance SheetCash FlowRatios

FLNA Balance Sheet

Quarterly statement

FLNA Balance Sheet

Filana Therapeutics, Inc. (FLNA) balance sheet — 27-year assets, liabilities & shareholders' equity history

AnnualQuarterly
MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21
Total Current Assets80.06M83.72M87.96M97.71M108.91M114.82M120.15M136.53M202.55M222.12M134M129.63M150.18M174.53M195M211.23M183.27M204.2M222.2M244.48M
Cash & Short-Term Investments46.99M82.68M86.57M95.5M106.08M112.38M117.33M128.57M148.98M207.29M124.17M121.14M142.35M168.44M187.47M201.01M174.66M197.23M209.69M233.44M
Cash Only46.99M82.68M86.57M95.5M106.08M112.38M117.33M128.57M148.98M207.29M124.17M121.14M142.35M168.44M187.47M201.01M174.66M197.23M209.69M233.44M
Short-Term Investments00000000000000000000
Accounts Receivable00117K120K817K835K864K947K6.28M1.44M1M962K1.28M0000000
Days Sales Outstanding--------------------
Inventory00000000000000000000
Days Inventory Outstanding--------------------
Other Current Assets33.07M1.03M1.02M1.59M107K134K162K38K40.19M13.39M8.45M6.78M5.41M6.09M277K160K79K6.96M12.17M10.38M
Total Non-Current Assets20M20.18M20.4M20.65M20.82M20.56M20.78M21M21.2M21.45M21.72M22.03M22.34M22.71M23.11M23.61M24.01M23.18M21.99M22.3M
Property, Plant & Equipment20M20.18M20.4M20.65M20.82M20.56M20.78M20.96M21.14M21.36M21.6M21.85M22.08M22.33M22.61M22.99M23.27M22.32M21.05M20.83M
Fixed Asset Turnover--------------------
Goodwill00000000000000000000
Intangible Assets000000037K69K82K115K176K268K387K503K622K740K859K940K1.07M
Long-Term Investments00000000000000000000
Other Non-Current Assets0000000000000000000399K
Total Assets100.06M103.9M108.37M118.36M129.73M135.38M140.93M157.53M223.75M243.57M155.72M151.66M172.53M197.25M218.11M234.83M207.29M227.38M244.19M266.78M
Asset Turnover--------------------
Asset Growth %-22.87%-23.25%-23.11%-24.87%-42.02%-44.42%-----28.61%-35.42%-16.77%-13.25%-10.68%-11.98%-24.42%-19.17%-14.03%182.91%
Total Current Liabilities41.95M40.16M40.12M43.83M48.05M47.33M13.24M11.75M57.03M54.59M77.12M14.2M17.41M17.89M13.91M7.06M8.31M8.72M6.79M12.53M
Accounts Payable039.29M39.19M6.4M46.09M42.82M8.19M7.65M52.24M52.55M9.6M10.57M9.49M10.34M8.24M4.02M3.53M4.76M3.33M7.13M
Days Payables Outstanding-11.9K8.44K6.58K-----63.94K215.92206.03146.799.63K13683.0669.63102.4781.59251.5
Short-Term Debt00000000000000000000
Deferred Revenue (Current)00000000000000000000
Other Current Liabilities41.95M482K680K35.81M588K722K968K1.66M2.25M1.82M67.29M3.42M7.74M293K391K662K576K370K3.19M631K
Current Ratio1.91x2.08x2.19x2.23x2.27x2.43x9.08x11.62x3.55x4.07x1.74x9.13x8.62x9.75x14.02x29.91x22.06x23.41x32.73x19.51x
Quick Ratio1.91x2.08x2.19x2.23x2.27x2.43x9.08x11.62x3.55x4.07x1.74x9.13x8.62x9.75x14.02x29.91x22.06x23.41x32.73x19.51x
Cash Conversion Cycle--------------------
Total Non-Current Liabilities136K136K111K118K119K79K79K79K80K00000197K232K259K289K308K333K
Long-Term Debt00000000000000000000
Capital Lease Obligations00000000000000035K62K88K114K139K
Deferred Tax Liabilities00000000000000000000
Other Non-Current Liabilities136K136K111K118K119K79K79K79K80K00000197K197K197K201K194K194K
Total Liabilities42.08M40.29M40.23M43.95M48.16M47.41M13.32M11.83M57.11M54.59M77.12M14.2M17.41M17.89M14.11M7.29M8.57M9.01M7.1M12.87M
Total Debt000000000000000139K164K188K213K236K
Net Debt-46.99M-82.68M-86.57M-95.5M-106.08M-112.38M-117.33M-128.57M-148.98M-207.29M-124.17M-121.14M-142.35M-168.44M-187.47M-200.88M-174.5M-197.04M-209.48M-233.2M
Debt / Equity---------------0.00x0.00x0.00x0.00x0.00x
Debt / EBITDA--------------------
Net Debt / EBITDA--------------------
Interest Coverage--------------------
Total Equity57.98M63.61M68.14M74.4M81.57M87.97M127.62M145.7M166.64M188.97M78.6M137.47M155.12M179.35M204M227.54M198.72M218.37M237.09M253.91M
Equity Growth %-28.92%-27.69%-46.6%-48.94%-51.05%-53.45%-----61.47%-39.58%-21.94%-17.87%-13.96%-10.39%-25.73%-21.02%-15.68%175.4%
Book Value per Share1.201.321.411.541.691.822.640.033.474.091.783.263.694.294.895.584.965.465.936.35
Total Shareholders' Equity57.98M63.61M68.14M74.4M81.57M87.97M127.62M145.7M166.64M188.97M78.6M137.47M155.12M179.35M204M227.54M198.72M218.37M237.09M253.91M
Common Stock583.72M48K48K48K48K48K48K48K48K48K43K42K42K42K42K42K40K40K40K40K
Retained Earnings-525.74M-515.02M-506.42M-496.08M-483.55M-472.74M-428.51M-405.11M-377.51M-349.57M-355.73M-380.77M-359.85M-334.2M-307.82M-283.55M-264.42M-244.16M-224.83M-207.31M
Treasury Stock00000000000000000000
Accumulated OCI00000000000000000000
Minority Interest00000000000000000000